Edwards Lifesciences (EW) PT Raised to $103 at Canaccord Genuity

Go back to Edwards Lifesciences (EW) PT Raised to $103 at Canaccord Genuity

Edwards Lifesciences (EW) PT Raised to $105 at Piper Sandler

April 21, 2021 9:22 AM EDT

Piper Sandler analyst Adam Maeder raised the price target on Edwards Lifesciences (NYSE: EW) to $105.00 (from $97.00) while maintaining a Overweight rating.

... More

Edwards Lifesciences (EW) PT Raised to $103 at Stifel

April 21, 2021 8:16 AM EDT

Stifel analyst Rick Wise raised the price target on Edwards Lifesciences (NYSE: EW) to $103.00 (from $100.00) while maintaining a Buy rating.

The analyst commented, "Overall, Edwards better-than-expected 1Q21 results marked a solid start to 2021, and post-release recovery trend/guidance commentary left us feeling... More

Edwards Lifesciences (EW) PT Raised to $110 at Jefferies

April 21, 2021 8:09 AM EDT

Jefferies analyst Raj Denhoy raised the price target on Edwards Lifesciences (NYSE: EW) to $110.00 (from $105.00) while maintaining a Buy rating.

The analyst commented, "EW posted $60mn/$0.07 beat with US TAVR flat offset by a rebound OUS to low DDs(HSD in... More

Edwards Lifesciences (EW) PT Raised to $93 at Wells Fargo

April 21, 2021 6:23 AM EDT

Wells Fargo analyst Lawrence Biegelsen raised the price target on Edwards Lifesciences (NYSE: EW) to $93.00 (from $87.00) while maintaining a Equal Weight rating.... More

Edwards Lifesciences (EW) PT Raised to $108 at Morgan Stanley

April 21, 2021 3:57 AM EDT

Morgan Stanley analyst Cecilia Furlong raised the price target on Edwards Lifesciences (NYSE: EW) to $108.00 (from $99.00) while maintaining a Overweight rating.... More

After-Hours Stock Movers 04/20: (LRN) (EW) (ISRG) Higher; (NFLX) (ROKU) (FUBO) Lower (more...)

April 20, 2021 5:20 PM EDT

Today's After-Hours Movers

Netflix (NASDAQ: NFLX) 10.5% LOWER; reported Q1 EPS of $3.75, $0.78 better than the analyst estimate of $2.97. Revenue for the quarter came in at $7.16 billion versus the consensus estimate of $7.13 billion. Global streaming paid net additions were 3.98 million versus the guidance of 6 million. The company sees Q2 Global... More

Edwards Lifesciences (EW) Tops Q1 EPS by 6c, Revenues Beat; Offers FY21 EPS Outlook

April 20, 2021 4:17 PM EDT

Edwards Lifesciences (NYSE: EW) reported Q1 EPS of $0.54, $0.06 better than the analyst estimate of $0.48. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.16 billion.

First Quarter Highlights and 2021 Outlook

Sales grew 8 percent to $1.2 billion; underlying1 sales grew 5 percentTAVR sales grew 7 percent; underlying sales... More